JPWO2022154121A1 - - Google Patents

Info

Publication number
JPWO2022154121A1
JPWO2022154121A1 JP2022575666A JP2022575666A JPWO2022154121A1 JP WO2022154121 A1 JPWO2022154121 A1 JP WO2022154121A1 JP 2022575666 A JP2022575666 A JP 2022575666A JP 2022575666 A JP2022575666 A JP 2022575666A JP WO2022154121 A1 JPWO2022154121 A1 JP WO2022154121A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2022575666A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022154121A1 publication Critical patent/JPWO2022154121A1/ja
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2022575666A 2021-01-18 2022-01-17 Abandoned JPWO2022154121A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021005702 2021-01-18
PCT/JP2022/001421 WO2022154121A1 (ja) 2021-01-18 2022-01-17 ヘプシジンの吸着抑制剤、吸着抑制方法、標準品、試薬、キットおよび測定方法

Publications (1)

Publication Number Publication Date
JPWO2022154121A1 true JPWO2022154121A1 (https=) 2022-07-21

Family

ID=82448196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022575666A Abandoned JPWO2022154121A1 (https=) 2021-01-18 2022-01-17

Country Status (4)

Country Link
US (1) US20230358753A1 (https=)
EP (1) EP4279924A4 (https=)
JP (1) JPWO2022154121A1 (https=)
WO (1) WO2022154121A1 (https=)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006517198A (ja) * 2002-11-19 2006-07-20 ディーアールジー・インターナショナル,インコーポレイテッド ヒトまたは動物の組織、血液もしくは体液中のヘプシジンをスクリーニングすることによる疾患の診断方法およびそのための治療的使用
JP2010517529A (ja) * 2007-02-02 2010-05-27 アムジエン・インコーポレーテツド ヘプシジン及びヘプシジン抗体
JP2010539969A (ja) * 2007-10-02 2010-12-24 アンセルム(アンスチチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル) ヒトヘプシジンに対して特異性を有する抗原結合タンパク質
US20120040894A1 (en) * 2008-12-05 2012-02-16 Tomas Ganz Mini-Hepcidin Peptides and Methods of Using thereof
US20150369821A1 (en) * 2013-02-06 2015-12-24 Pieris Ag Novel lipocalin-mutein assays for measuring hepcidin concentration
JP2016513664A (ja) * 2013-03-15 2016-05-16 イントリンシック ライフサイエンシズ リミテッド ライアビリティ カンパニー 抗ヘプシジン抗体およびその使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3580388B2 (ja) * 1996-01-25 2004-10-20 栄研化学株式会社 非特異反応の抑制方法
US7270969B2 (en) * 1999-05-05 2007-09-18 Phylogica Limited Methods of constructing and screening diverse expression libraries
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
JP4098796B2 (ja) 2005-07-13 2008-06-11 義一 佐渡 マウス腸骨リンパ節を用いたモノクローナル抗体の作製
WO2009039485A1 (en) * 2007-09-20 2009-03-26 University Of Utah Research Foundation Electrochemical deposition of polymers on metal substrates
WO2009055078A2 (en) * 2007-10-26 2009-04-30 University Of Utah Research Foundation Identification of the hepcidin binding site on ferroportin
EA201170312A1 (ru) * 2008-08-06 2012-03-30 Эли Лилли Энд Компани Селективные антитела к гепцидину-25 и их применение
WO2012169453A1 (ja) 2011-06-07 2012-12-13 和光純薬工業株式会社 凝集促進剤
CN112345772A (zh) * 2020-10-29 2021-02-09 江苏沃兴生物科技有限公司 一种基于单克隆抗体制备的铁调素的胶乳增强比浊法检测试剂盒

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006517198A (ja) * 2002-11-19 2006-07-20 ディーアールジー・インターナショナル,インコーポレイテッド ヒトまたは動物の組織、血液もしくは体液中のヘプシジンをスクリーニングすることによる疾患の診断方法およびそのための治療的使用
JP2010517529A (ja) * 2007-02-02 2010-05-27 アムジエン・インコーポレーテツド ヘプシジン及びヘプシジン抗体
JP2010539969A (ja) * 2007-10-02 2010-12-24 アンセルム(アンスチチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル) ヒトヘプシジンに対して特異性を有する抗原結合タンパク質
US20120040894A1 (en) * 2008-12-05 2012-02-16 Tomas Ganz Mini-Hepcidin Peptides and Methods of Using thereof
US20150369821A1 (en) * 2013-02-06 2015-12-24 Pieris Ag Novel lipocalin-mutein assays for measuring hepcidin concentration
JP2016513664A (ja) * 2013-03-15 2016-05-16 イントリンシック ライフサイエンシズ リミテッド ライアビリティ カンパニー 抗ヘプシジン抗体およびその使用
JP2019037236A (ja) * 2013-03-15 2019-03-14 イントリンシック ライフサイエンシズ リミテッド ライアビリティ カンパニー 抗ヘプシジン抗体およびその使用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
QUANTIKINE ELISA HUMAN HEPCIDIN IMMUNOASSAY, vol. Catalog Number DHP250, JPN6025040362, 2019, pages 1 - 10, ISSN: 0005702809 *

Also Published As

Publication number Publication date
EP4279924A1 (en) 2023-11-22
US20230358753A1 (en) 2023-11-09
WO2022154121A1 (ja) 2022-07-21
EP4279924A4 (en) 2024-06-26

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
JPWO2022154121A1 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241004

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250701

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250829

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251007

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20251203